Olendalizumab
Product Specifications
CAS Number
2210314-30-8
Target
Complement System
Related Pathways
Immunology/Inflammation
Bioactivity
Olendalizumab (ALXN1007), a humanized IgG2-G4-? antibody derived from mice, specifically targets Complement protein C5a with a binding affinity (K i) of 60 pM. This compound is designed to inhibit the complement inflammatory pathway. Additionally, olendalizumab is utilized in the research of complement-mediated disorders triggered by the coronavirus [1] [2].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
040246-ML405 100 µL
POLI, CT (POLI, RAD30B, DNA polymerase iota, Eta2, RAD30 homolog B) (MaxLight 405) discontinued
Ask
View Details 